Sponsored by

NovoCure Trial

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1201 to 1225 of about 5897

Previous 25

Website Changes

10/12/2018

Bevacizumab: Is the lower the better for glioblastoma patients in progression?

10/04/2018

Novocure Announces 55 Presentations at European Association of Neuro-Oncology Meeting 2018

09/20/2018

Experimental drug `nothing short of miraculous` for father of 4 with super-rare brain tumor

09/17/2018

Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.

09/14/2018

Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition.

09/14/2018

Brain Tumor Webinar Series: Gamma Knife Radiosurgery Sunday, 9/16/18

09/13/2018

Moleculin’s Brain Cancer Drug Candidate Begins Patient Dosing at Clinical Trial Being Conducted at MD Anderson

09/13/2018

Researchers make breakthrough in understanding aggressive brain cancer

09/10/2018

Patient Foundation Collaboration to Advance ONC201 in DIPG and other H3 K27M-mutant Gliomas

09/10/2018

NCI and Musella Foundation Award Grants for ONC201 Trials in Adult and Pediatric Brain Tumors

09/10/2018

Intra-tumoral treatment with oxygen-ozone in glioblastoma: A systematic literature search and results of a case series

09/06/2018

KKCO - Daybreak Anchor Sarah Schwabe`s Connection To Glioblastoma

09/06/2018

Optune Open House: St. Louis, MO

09/04/2018

Dellann Elliott Mydland, President of the EndBrainCancer Initiative, to Serve on Two National Clinical Trial Committees for NRG Oncology, an NCI-Funded Research Group

09/04/2018

Musella Foundation Copay Assistance Program is now open!

09/01/2018

This brain cancer drug stock has been on a tear

08/29/2018

Optune open house Seattle, WA

08/27/2018

Aspirin affects tumor angiogenesis and sensitizes human glioblastoma endothelial cells to temozolomide, bevacizumab, and sunitinib impairing VEGF-related signaling.

08/24/2018

New glioblastoma clinical trial: mTOR inhibitor ABI-009

08/24/2018

Tocagen`s Toca 5 Pivotal Phase 3 Clinical Trial in Patients with Recurrent Brain Cancer Continues Without Modification at Planned First Interim Analysis

08/23/2018

Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations

08/23/2018

Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.

08/23/2018

CLINICAL TRIAL TO DISRUPT THE BLOOD-BRAIN BARRIER FOR BRAIN TUMOR TREATMENT LAUNCHED AT UNIVERSITY OF MARYLAND

08/22/2018

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

08/16/2018

5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.

Our privacy / cookie policy has changed.
Click HERE to read it!